Decent Holding Shareholders Greenlight 1B Share Authorization and Reverse Split
DXST sits 43% above its 52-week low of $1.5 on light trading volume (0.1× avg).
Summary
At today's extraordinary general meeting, Decent Holding shareholders approved all proposals, including an increase in authorized shares to 1 billion and a reverse stock split authorization at a ratio between 1-for-10 and 1-for-250, with the board to determine the exact terms within one year.
Key Events · Corporate Governance and Compliance · DXST
-
Authorized Shares Increased to 1 Billion
Shareholders voted to raise the authorized share capital from 20 million to 1 billion shares, creating 880.2 million new Class A and 99.8 million new Class B ordinary shares.
-
Reverse Stock Split Authorized
The board now has the authority to implement one or more reverse stock splits at a ratio between 1-for-10 and 1-for-250, with the exact ratio and timing left to its discretion within one year.
-
Potential Dilution Impact
If all newly authorized shares were issued, dilution would be extreme given the current ~1.8 million shares outstanding, though no immediate issuance is planned.
-
Reverse Split Could Address Nasdaq Compliance
The reverse split authorization may be used to lift the stock price above $1.00 to meet Nasdaq minimum bid requirements, though the company has not stated this explicitly.
Analysis · DXST · Energy & Transportation
Today's vote clears the way for a dramatic expansion of authorized shares to 1 billion and empowers the board to execute a reverse stock split at a ratio between 1-for-10 and 1-for-250 within the next year. The authorization, which follows the June 22 proxy filing, introduces the potential for significant dilution and a share consolidation that could fundamentally reshape the stock's trading profile. Notably, the reverse split details represent new information not included in the prior proxy statement.
At the time of this filing, DXST was trading at $2.15 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $3.9M. The 52-week trading range was $1.50 to $62.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.